The risk of developing a second cancer after receiving craniospinal proton irradiation. - Wikidata - awgldk - TriplyDB

The risk of developing a second cancer after receiving craniospinal proton irradiation.

The risk of developing a second cancer after receiving craniospinal proton irradiation.

http://www.wikidata.org/entity/Q34086830

about

A Review of Radiotherapy-Induced Late Effects Research after Advanced Technology Treatments Secondary Malignancy Risk Following Proton Radiation Therapy Ionizing Particle Radiation as a Modulator of Endogenous Bone Marrow Cell Reprogramming: Implications for Hematological Cancers Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients.Assessing the risk of second malignancies after modern radiotherapy Monte Carlo simulation of the neutron spectral fluence and dose equivalent for use in shielding a proton therapy vault Benchmark measurements and simulations of dose perturbations due to metallic spheres in proton beams.Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.Promise and pitfalls of heavy-particle therapy.Influence of beam efficiency through the patient-specific collimator on secondary neutron dose equivalent in double scattering and uniform scanning modes of proton therapy.REDUCING STRAY RADIATION DOSE FOR A PEDIATRIC PATIENT RECEIVING PROTON CRANIOSPINAL IRRADIATION Emerging role of radiation induced bystander effects: Cell communications and carcinogenesis.Anonymization of DICOM electronic medical records for radiation therapy Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy.Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy.ADVANTAGES OF MCNPX-BASED LATTICE TALLY OVER MESH TALLY IN HIGH-SPEED MONTE CARLO DOSE RECONSTRUCTION FOR PROTON RADIOTHERAPY.A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.GRID-ENABLED TREATMENT PLANNING FOR PROTON THERAPY USING MONTE CARLO SIMULATIONS.Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans The role of radiotherapy in Hodgkin's lymphoma: what has been achieved during the last 50 years?Inter-Institutional Comparison of Personalized Risk Assessments for Second Malignant Neoplasms for a 13-Year-Old Girl Receiving Proton versus Photon Craniospinal Irradiation.Implementation of an analytical model for leakage neutron equivalent dose in a proton radiotherapy planning system.Analytical model for out-of-field dose in photon craniospinal irradiation The physics of proton therapy.Proton radiotherapy for pediatric tumors: review of first clinical results.Visualization of risk of radiogenic second cancer in the organs and tissues of the human body.Risk-optimized proton therapy to minimize radiogenic second cancers.Reducing the cost of proton radiation therapy: the feasibility of a streamlined treatment technique for prostate cancer.The future workforce in cancer prevention: advancing discovery, research, and technology.Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients Life years lost--comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale Microdosimetric measurements for neutron-absorbed dose determination during proton therapy.Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy Standardized treatment planning methodology for passively scattered proton craniospinal irradiation.Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.

P2860

Q26767255-D685EAA2-521B-4673-823D-7B73669CEAEF Q26774492-7BA56294-A469-406B-9980-BDEC9FAD6288 Q26777120-93586F5B-EEFF-4D3B-A8E0-DA3689830F48 Q28267052-CCDDF308-8BCF-4DF3-8B7D-6843155E9910 Q33716537-752B0F9C-27AE-49C9-9F09-910AFA06DC35 Q33914324-52B59D0B-C173-4D71-BB92-D48996901931 Q33998333-6231AC34-3ED3-4C3A-AB90-F4EB26F2971C Q34060379-87051418-E6F8-4A96-9DD8-FC4A7E5418E0 Q34081025-80B7FDF0-51D3-4DAE-B4AA-7DAE62457B9B Q34124263-DFBC97B6-3656-4D73-8D20-865887401B96 Q34126066-304B2D01-1FC3-458B-A135-AC74906C0C81 Q34145162-C40D3D3F-9C73-4C11-AD0A-C614CA91CAA2 Q34173857-42F19B64-556D-4476-B329-6E6751F4D045 Q34218944-5F249CA1-8384-438E-80EA-B909BEFFA204 Q34350198-91CB2EB8-805B-423E-AB0D-AADC530E5594 Q34402663-6F73126E-C3CD-4F71-84B7-C1B2FE8EA380 Q34402676-921B661C-1EE6-41AB-A70B-39752CD9680D Q34402785-F0C919EC-AD46-4DE4-BF1B-0915DE5BEDDF Q34402847-4802F8D7-C925-43AD-B76E-73F33D42783D Q34575096-4F0357AA-B0AC-43D9-BA3F-62EBA1DC5909 Q34633178-53F52D48-D695-4E64-B96D-66FFD63C824E Q34653285-B7A3D8AA-5164-4E9F-BD5B-3748E4903D42 Q34666728-0554581B-6ED5-4DDE-A108-98CE65216082 Q35091669-FD725347-6B3F-4B8D-86A6-C0450870AF11 Q35237529-5DC5A77B-573D-4916-AE08-73FAF8EB1BF7 Q35237533-98DD4D21-4F8B-4BC9-A2D2-27F85D4966A1 Q35398974-D371846E-456E-4256-AFF0-38046D9F74CE Q35531022-16ECADCE-B7DE-4F74-B4D8-85B90176C550 Q35575119-EBBE45EA-E1D0-47DC-9F11-78F0D5EA681F Q35576919-7155E1F7-4FEF-4142-BF4A-AB98CE48CDB7 Q35646914-FC9FCF8E-0CD7-4A1E-A9E3-677974FF79DC Q35818426-323C4DA7-2530-49BA-9691-FFE37325E59F Q35951633-BF0570EA-773A-49A3-98A5-7FEF925BE32D Q36038142-1F5AA067-389E-41F7-8567-74540AD26824 Q36110194-64E02CD1-D990-45EB-9509-AA0553C4A724 Q36174155-3D9E1EB9-C650-4DFD-AAFA-DA55F029DC3F Q36298040-9284C2BF-0E57-4910-9464-ED0C33B12627 Q36710649-DE9E2569-3BE3-4117-BF0E-518F4A67D0BD Q36736612-A6D392EA-E15D-47AF-95DD-231818734F28 Q36737527-82241B82-7258-4093-A031-BB1BDBC586CD

P2860

The risk of developing a second cancer after receiving craniospinal proton irradiation.

http://www.wikidata.org/entity/Q34086830

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@ast

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@en

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@nl

type

label

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@ast

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@en

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@nl

prefLabel

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@ast

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@en

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@nl

P1433

Q34086830-F01FA0DD-29F0-43B9-8702-6AD8407966EB

P1476

Q34086830-2D517C62-625D-408F-B69F-AFB05B288644

P2093

Q34086830-1270C9D9-FF46-4961-9CBC-293AE59C3130

Q34086830-137089AB-FB2B-4B24-85E6-527AAC58DC67

Q34086830-2DEE8EC4-B0C3-4AF1-A559-ADD651062D98

Q34086830-4A56604B-6F32-4C63-B85A-F28C073045F2

Q34086830-D76B7CA2-0573-4A0E-8D4F-BA8F7C72191F

Q34086830-DCA6CCC4-B21F-457B-9F48-90CFD151F21C

Q34086830-EE440759-7225-4093-A087-82B24B48DE8F

Q34086830-F5180A15-B656-4BB6-90FB-DF970A21D812

Q34086830-F889AB59-7D33-4CE7-A4B0-60A9A06925F0

Q34086830-FB43C517-35C7-47DB-9C73-6928726B4A70

P2860

Q34086830-0C00E9C9-62C1-49EA-B7B7-9C0F78ECA350

Q34086830-0D4F71A4-62D7-4E8D-8013-519FF5764DC6

Q34086830-1BBDAEF9-2723-4EF9-87E6-54488C8D4C0E

Q34086830-1E99A026-5CE9-432B-9A9B-FE438E72319D

Q34086830-240D1456-59AF-42E2-946B-4958F8103F38

Q34086830-2B2D7EEC-C92A-421A-949D-16A17D42AAAD

Q34086830-416CA6BA-3499-419C-8AFF-B7349A0E3CE6

Q34086830-45E4F697-8B08-4448-B6AC-6B23D22A793F

Q34086830-4A326E00-4D85-42D3-821A-FA62233D634E

Q34086830-4FA5FC9B-EB3F-40CD-870B-3294C2613B9F

P304

Q34086830-BA7815E5-0D52-4DA0-A74F-BAF62277D944

P31

Q34086830-5CF73893-BAE3-4353-B326-865314DA11DD

P356

Q34086830-6DB28D1B-9476-48B0-8F9D-A1EC96D0079B

P433

Q34086830-F155B3CD-50C4-4795-9108-473C0C8DE3B9

P478

Q34086830-1DBBC2E2-5807-4387-812F-520036247F15

P50

Q34086830-236AB0B9-5CD6-422F-9FB8-6C1AA9976277

P577

Q34086830-CDA9BA05-E8C9-4470-A646-084191A86D82

P5875

Q34086830-0B9C0EC7-C31B-49B2-B479-5944721E852D

P698

Q34086830-1BDC62BA-FC30-4592-97A6-975702F6285C

P932

Q34086830-9059CCE9-CBC5-423C-A3BB-B2F688F1192E

P356

P1433

Physics in Medicine and Biology

P1476

The risk of developing a second cancer after receiving craniospinal proton irradiation.

@en

P2093

Anita Mahajan

http://www.w3.org/2001/XMLSchema#string

David Kornguth

http://www.w3.org/2001/XMLSchema#string

Dragan Mirkovic

http://www.w3.org/2001/XMLSchema#string

James D Cox

http://www.w3.org/2001/XMLSchema#string

Jonas D Fontenot

http://www.w3.org/2001/XMLSchema#string

Marilyn Stovall

http://www.w3.org/2001/XMLSchema#string

Phillip J Taddei

http://www.w3.org/2001/XMLSchema#string

Shiao Woo

http://www.w3.org/2001/XMLSchema#string

Wayne D Newhauser

http://www.w3.org/2001/XMLSchema#string

Yuanshui Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Anesthesia safety: model or myth? A review of the published literature and analysis of current original data.

Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.

Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.

Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer.

Radiation effects on breast cancer risk: a pooled analysis of eight cohorts.

Stereotactic heavy-charged-particle Bragg-peak radiation for intracranial arteriovenous malformations.

Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection.

Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma.

Intensity-modulated radiation therapy, protons, and the risk of second cancers.

Spread-out Bragg peak and monitor units calculation with the Monte Carlo code MCNPX.

P304

2277-2291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1088/0031-9155/54/8/002

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24218457

http://www.w3.org/2001/XMLSchema#string

P698

19305036

http://www.w3.org/2001/XMLSchema#string

P932

4144016

http://www.w3.org/2001/XMLSchema#string